24
nanotimes
Companies Facts
I
n an interview with Capital Situation, Michael Siegel, CEO of EcoloCap Solutions of Chicago,
USA, stated that numerous independent tests have proven the company’s M-Fuel technology to reduce consumption of diesel fuel up to 30% while redu- cing emissions by over 70%, without any modifica- tions to diesel engines of buses and trucks. Invented using nanotechnology, M-Fuel is an emul- sion of diesel fuel, water and a proprietary additive, developed by EcoloCap’s Korean team over the last few years. The Company is presently marketing the technology worldwide, having orders and memoran- dum of understanding with, governments, transporta- tion and utility companies in over ten countries.
Siegel stated: “Taking an example in our own back- yard, the skyrocketing price of diesel fuel will cost Chicago and Chicago‘s transit agencies tens of millions of dollars more than anticipated this year, jeopardizing some proposed new services. With fuel costs rising and state funds scarce, the region‘s mass transit agencies face a budget season full of tough de- cisions that could create a bumpy ride for passengers. The City of Chicago, along with Pace, the CTA, and Metra spend an estimated $200M in diesel fuel each year. The use of EcoloCap’s M-Fuel would save a minimum of 20% or some $40M annually, and that’s using the most conservative of our projections.”
Siegel added: “Another factor is that under the 2003 Clean Air Act [U.S.], emulsified diesel fuels with a minimum 12.5% water make users eligible for an ad- ditional $0.197 IRS Tax Credit. As a result, end users could save up to $1.00 a gallon on the cost of diesel fuel at today’s prices.”
http://www.ecolocap.com
E E
lionix Inc. announced a second order placed by Harvard‘s Center for Nanoscale Systems for the
Elionix ELS-F125 electron beam lithography system.
http://www.sts-elionix.com
NVISION ALR is commercialising a new form of nanotechnology based infectious disease detec-
tion system with the capability to distinguish between different flu strains within seconds. The technology has already been shown to be effective in lab tests and the company is accelerating the commerciali- sation program. The technology is based on printed electronics, making use of the unique properties of a number of nanoparticle based inks and is rapid, accurate, and the hand held device is easily portable for use in doctors surgeries, hospitals or airports. The system works for both bacterial and viral pathogens, and tests performed by the Naval Research Lab in Washington DC using Staphylococcus Enterotoxin B showed a two order of magnitude improvement over the current ‚Lab Golden Standard‘ test.
http://envisionalr.co.uk
F
luidigm Corporation (NASDAQ:FLDM) has intro- duced its 192.24 Dynamic Array™ IFC, designed
to genotype 192 samples against 24 SNP assays in a single run, providing 4,608 data points in just one hour. The 192.24 integrated fluidic circuit (IFC) has immediate applicability in agricultural biotechnolo- gy and genome wide association studies. Fluidigm‘s latest integrated fluidic circuit features an innovative design that greatly increases sample throughput for common SNP genotyping applications. Moreover, Fluidigm has announced that the Broad Institute of MIT and Harvard has purchased an
11-05 :: May/June 2011
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95